Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 3/20 | 0.50 |
| ▸ | NOS3 | P29474 | 2/20 | 0.30 |
| ▸ | NOS1 | P29475 | 2/20 | 0.30 |
| ▸ | NOS2 | P35228 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6867646 | 1.00 | FUCA1 (0.50) | FUCA1NOS3NOS1NOS2 | |
| SCHEMBL6870012 | 1.00 | FUCA1 (0.50) | FUCA1NOS3NOS1NOS2 | |
| SCHEMBL15628060 | 0.93 | FUCA1 (0.46) | FUCA1 | |
| SCHEMBL798748 | 0.91 | — | — | |
| SCHEMBL15107903 | 0.91 | — | — | |
| SCHEMBL12855703 | 0.91 | — | — | |
| SCHEMBL16109261 | 0.91 | — | — | |
| SCHEMBL14094624 | 0.91 | — | — | |
| SCHEMBL10050297 | 0.91 | — | — | |
| SCHEMBL13576467 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207733-B1 | HARDENERS PRODUCED BY REACTING AMINE HAVING TWO PRIMARY AMINES WITH CYCLIC ALKYLENE CARBONATE TO FORM HYDROXYALKYLURETHANE, THEN WITH ALIPHATIC CARBONYL COMPOUND TO FORM KETIMINE, THEN LINKING WITH MULTIFUNCTIONAL HYDROXY-REACTIVE COMPOUND | VIANOVA RESINS AG (AU) | 2001-03-27 | — | — | US | claimed |
| WO-2022054786-A1 | POLARIZING FILM CONTAINING AZO COMPOUND OR SALT THEREOF, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | 日本化薬株式会社 | 2022-03-17 | — | — | WO | disclosed |
| EP-3372624-A1 | ONE COMPONENT COMPOSITION BASED ON COMPOUNDS WITH AT LEAST TWO EXO-VINYLENE CYCLIC CARBONATE UNITS | Henkel AG & Co. KGaA (DE) | 2018-09-12 | — | — | EP | disclosed |
| US-6818772-B2 | DIETETICS, SLEEP DISORDERS, EATING DISORDERS, SEXUAL DISORDERS, CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS | ABBOTT LABORATORIES | 2004-11-16 | — | — | US | disclosed |
| EP-0957121-B1 | Blocked amines as curing agent for aqueous epoxy one component resin compositions | SURFACE SPECIALTIES AUSTRIA (AT) | 2004-02-04 | — | — | EP | disclosed |
| US-20030229119-A1 | Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor | ABBVIE INC. | 2003-12-11 | — | — | US | disclosed |
| WO-2003070244-A1 | ANTAGONIST OF MELANIN CONCENTRATING HORMONE AND THEIR USES | ABBOTT LABORATORIES (US) | 2003-08-28 | — | — | WO | disclosed |
| EP-0859032-B1 | Bridged anthraquinones | BAYER AG (DE) | 2001-11-21 | — | — | EP | disclosed |
| US-6207733-B1 | HARDENERS PRODUCED BY REACTING AMINE HAVING TWO PRIMARY AMINES WITH CYCLIC ALKYLENE CARBONATE TO FORM HYDROXYALKYLURETHANE, THEN WITH ALIPHATIC CARBONYL COMPOUND TO FORM KETIMINE, THEN LINKING WITH MULTIFUNCTIONAL HYDROXY-REACTIVE COMPOUND | VIANOVA RESINS AG (AU) | 2001-03-27 | — | — | US | disclosed |
| EP-0957121-A2 | Blocked amines as curing agent for aqueous epoxy one component resin compositions | Vianova Resins AG (AT) | 1999-11-17 | — | — | EP | disclosed |
| US-5912386-A | Bridged anthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1999-06-15 | — | — | US | disclosed |
| EP-0859032-A1 | Bridged anthraquinones | BAYER AG (DE) | 1998-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229119-A1 | Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor | MCHR1, MCHR2, MC1R | FUCA1 3010/4885NOS3 2296/4885NOS1 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.